Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

View source ↗

Summary

This clinical trial update discusses evaluating sentinel lymph node biopsy in early-stage, palpable node-positive HR+/HER2- breast cancer patients undergoing up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING